Differential serological diagnosis of HTLV-I and HTLV-II infection by external membrane protein peptide-based enzyme immunoassays (Q39166416)

9 September 2017

Differential serological diagnosis of HTLV-I and HTLV-II infection by external membrane protein peptide-based enzyme immunoassays (English)

1 reference

Human T-lymphotropic virus 1

9 September 2017

0 references

1 reference

Lee HH

1

1 reference

9 September 2017

Shih J

2

1 reference

9 September 2017

O'Donnell D

3

1 reference

9 September 2017

Swanson P

4

1 reference

9 September 2017

Mann T

5

1 reference

9 September 2017

Allain JP

6

1 reference

9 September 2017

1 May 1997

1 reference

Clinical and diagnostic virology

9 September 2017

1 reference

9 September 2017

8

1 reference

9 September 2017

1

1 reference

9 September 2017

9-16

1 reference

Molecular characterization of genome of a novel human T-cell leukaemia virus

9 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2897%2900272-9

7 January 2021

Type-specific antigens for serological discrimination of HTLV-I and HTLV-II infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2897%2900272-9

7 January 2021

Incidence of hairy cell leukemia, mycosis fungoides, and chronic lymphocytic leukemia in first known HTLV-II-endemic population.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2897%2900272-9

7 January 2021

Second conserved domain of gp120 is important for HIV infectivity and antibody neutralization

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2897%2900272-9

7 January 2021

High prevalence of HTLV-II among intravenous drug abusers: PCR confirmation and typing

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2897%2900272-9

7 January 2021

Serologic discrimination of human T cell lymphotropic virus infection by using a synthetic peptide-based enzyme immunoassay

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2897%2900272-9

7 January 2021

High rate of HTLV-II infection in seropositive i.v. drug abusers in New Orleans.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2897%2900272-9

7 January 2021

Patterns of HIV-1 and HTLV-I/II in intravenous drug abusers from the middle atlantic and central regions of the USA.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2897%2900272-9

7 January 2021

Relative prevalence and risk factors of HTLV-I and HTLV-II infection in US blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2897%2900272-9

7 January 2021

Determination of a Unique and Immunodominant Epitope of Human T Cell Lymphotropic Virus Type I

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2897%2900272-9

7 January 2021

Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemialike cells

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2897%2900272-9

7 January 2021

Distinguishing between HTLV-I and HTLV-II by western blot

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2897%2900272-9

7 January 2021

HTLV-II infection in Italian drug abusers

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2897%2900272-9

7 January 2021

10.1016/S0928-0197(97)00272-9

Identifiers

DOI

1 reference

9 September 2017

1 reference